Suchergebnisse - (Subject:"IL6")

PubPharm (23.588)

11

Irisin alleviates obesity-induced bone loss by inhibiting interleukin 6 expression via TLR4/MyD88/NF-κB axis in adipocytes

enthalten in: Journal of advanced research | 2024

von Zhang, Y. | He, X. | Wang, K. | +6

12

Ginsenoside Re protects against kainate-induced neurotoxicity in mice by attenuating mitochondrial dysfunction through activation of the signal transducers and activators of transcription 3 signaling

enthalten in: Free radical research | 2024

von Nguyen, Y. | Jeong, J. | Sharma, N. | +9

13

Tumor cell-derived LC3B+extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis

enthalten in: Clinical immunology (Orlando, Fla.) | 2024

von Chen, Y. | Man, Z. | Zheng, L. | +8

14

MST1/2 regulates fibro/adipogenic progenitor fate decisions in skeletal muscle regeneration

enthalten in: Stem cell reports | 2024

von Wang, K. | Yang, J. | An, Y. | +4

15

Neutrophil response to Porphyromonas gingivalis is modulated by low-level laser application

enthalten in: Oral diseases | 2024

von Özkan Karasu, Y. | Öner, F. | Kantarci, A.

16

Evaluation of interleukin-1 and interleukin-6 receptor antagonists in a murine model of acute lung injury

enthalten in: Experimental physiology | 2024

von Meunier, �. | Aubin Vega, M. | Adam, D. | +6

17

Interleukin-6 promotes visceral adipose tissue accumulation during aging via inhibiting fat lipolysis

enthalten in: International immunopharmacology | 2024

von Zhang, X. | Wang, Q. | Wang, Y. | +10

18

Growth differentiation factor 15 and malnutrition in older adults

enthalten in: The journal of nutrition, health & aging | 2024

von Rostami, N. | Fabre-Estremera, B. | Buño-Soto, A. | +3

19

IL-6 is a predictor and potential therapeutic target for coronavirus disease 2019-related heart failure : A single-center retrospective study

enthalten in: Cytokine | 2024

von Xi, Y. | Mao, Y. | Zhu, W. | +5

20

MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors

enthalten in: International journal of clinical oncology | 2024

von Nagasaka, H. | Kishida, T. | Kouro, T. | +11